These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38160787)

  • 1. Chronic inflammation and cancer; the two sides of a coin.
    Fernandes Q; Inchakalody VP; Bedhiafi T; Mestiri S; Taib N; Uddin S; Merhi M; Dermime S
    Life Sci; 2024 Feb; 338():122390. PubMed ID: 38160787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation, a Double-Edge Sword for Cancer and Other Age-Related Diseases.
    Gupta SC; Kunnumakkara AB; Aggarwal S; Aggarwal BB
    Front Immunol; 2018; 9():2160. PubMed ID: 30319623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and cancer revisited: an hypothesis on the oncogenic potential of the apoptotic tumor cell.
    Gregory CD
    Autoimmunity; 2013 Aug; 46(5):312-6. PubMed ID: 23320865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 32, inflammation and cancer.
    Hong JT; Son DJ; Lee CK; Yoon DY; Lee DH; Park MH
    Pharmacol Ther; 2017 Jun; 174():127-137. PubMed ID: 28223235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inflammation and cancer: the role of the mitochondria.
    Kamp DW; Shacter E; Weitzman SA
    Oncology (Williston Park); 2011 Apr; 25(5):400-10, 413. PubMed ID: 21710835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases.
    Sipos F; Firneisz G; Műzes G
    World J Gastroenterol; 2016 Sep; 22(35):7938-50. PubMed ID: 27672289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and Prostate Cancer.
    Tewari AK; Stockert JA; Yadav SS; Yadav KK; Khan I
    Adv Exp Med Biol; 2018; 1095():41-65. PubMed ID: 30229548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the mediators of inflammation in cancer development.
    Fernandes JV; Cobucci RN; Jatobá CA; Fernandes TA; de Azevedo JW; de Araújo JM
    Pathol Oncol Res; 2015 Jul; 21(3):527-34. PubMed ID: 25740073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine Regulation of Metastasis and Tumorigenicity.
    Yao M; Brummer G; Acevedo D; Cheng N
    Adv Cancer Res; 2016; 132():265-367. PubMed ID: 27613135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming links chronic intestinal inflammation and the oncogenic transformation in colorectal tumorigenesis.
    Zhang S; Cao L; Li Z; Qu D
    Cancer Lett; 2019 May; 450():123-131. PubMed ID: 30851417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis as an immunopharmacologic target in inflammation and cancer.
    Bian XW; Chen JH; Jiang XF; Bai JS; Wang QL; Zhang X
    Int Immunopharmacol; 2004 Nov; 4(12):1537-47. PubMed ID: 15351323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR3, a double-edged sword in tumor progression and angiogenesis.
    Billottet C; Quemener C; Bikfalvi A
    Biochim Biophys Acta; 2013 Dec; 1836(2):287-95. PubMed ID: 23994549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance.
    Sabaawy HE; Ryan BM; Khiabanian H; Pine SR
    Carcinogenesis; 2021 Dec; 42(12):1411-1419. PubMed ID: 34415330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy.
    Patrad E; Khalighfard S; Amiriani T; Khori V; Alizadeh AM
    Cell Oncol (Dordr); 2022 Dec; 45(6):1073-1117. PubMed ID: 36149600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic inflammation and cancer.
    Shacter E; Weitzman SA
    Oncology (Williston Park); 2002 Feb; 16(2):217-26, 229; discussion 230-2. PubMed ID: 11866137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of Gastric Cancer-Promoting Inflammation: A Novel Strategy for Anti-cancer Therapy.
    Piazuelo MB; Riechelmann RP; Wilson KT; Algood HMS
    Curr Top Microbiol Immunol; 2019; 421():319-359. PubMed ID: 31123895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor dormancy and cancer stem cells: two sides of the same coin?
    Kleffel S; Schatton T
    Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin--one single nature.
    Harguindey S; Orive G; Luis Pedraz J; Paradiso A; Reshkin SJ
    Biochim Biophys Acta; 2005 Sep; 1756(1):1-24. PubMed ID: 16099110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fundamental role of mechanical properties in the progression of cancer disease and inflammation.
    Mierke CT
    Rep Prog Phys; 2014 Jul; 77(7):076602. PubMed ID: 25006689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.